Increased mast cell density in invasive melanoma

Journal of Cutaneous Pathology

Volumn 25, Issue 1, 1998, Pages 11-15

  Duncan, Lyn M ^a   Richards, Lisa A ^a   Mihm Jr , Martin C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAST CELL; MELANOMA; NEVUS; SKIN BIOPSY; TECHNIQUE; TISSUE SECTION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MAST CELLS; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEVUS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 0031984871     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01683.x     Document Type: Article

References (24)

1. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993: 142: 965.
2. Dvorak AM, Mihm MC Jr., Osage JE, Dvorak HF. Melanoma. An ultrastructural study of host inflammatory and vascular responses. J Invest Dermatol 1980: 75: 388.
3. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer 1988: 62: 2416.
4. Tomita Y, Aozasa K, Myoui A, et al. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including Ag-NOR count and mast-cell count. Int J Cancer 1993: 54: 194.
5. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol 1993: 17: 35.
6. McGinnis MC, Bradley ELJ, Pretlow TP, et al. Correlation of stromal cells by morphometric analysis with metastatic behavior of human colonie carcinoma. Cancer Res 1989: 49: 5989.
7. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol 1989: 20: 159.
8. Fisher ER, Sass R, Watkins G, Johal J, Fisher B. Tissue mast cells in breast cancer. Breast Cancer Res Treat 1985: 5: 285.
9. Schadendorf D, Kohlmus C, Gawlik C, Suter L, Czametzki BM. Mast cells in melanocytic tumors. Arch Dermatol Res 1995: 287: 452.
10. Mihm MC Jr., Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976: 67: 305.
11. Kasper CS, Tharp MD. Quantification of cutaneous mast cells using morphometric point counting and a conjugated avidin stain. J Am Acad Dermatol 1987: 16: 326.
12. Kasper CS, Freeman RG, Tharp MD. Diagnosis of mastocytosis subsets using a morphometric point counting technique. Arch Dermatol 1987: 123: 1017.
13. Muntz KH, Hagler HK, Boulas HJ, Willerson JT, Buja LM. Redistribution of catecholamines in the ischemic zone of the dog heart. Am J Pathol 1984: 114: 64.
14. Clark WH Jr., From L, Bernardino EA, Mihm MC Jr. The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 1969: 29: 705.
15. Horiuchi K, Mishima K, Ohsawa M, Sugimura M, Aozasa K. Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation. J Surg Oncol 1993: 53: 92.
16. Metcalfe DD, Mekori JA, Rottem M. Mast cell ontogeny and apoptosis. Exp Dermatol 1995: 4: 227.
17. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 1994: 424: 135.
18. Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ. Regulation of mouse and human mast cell development survivial and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 1995: 107: 51.
19. Funasaka Y, Boulton T, Cobb M, et al. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992: 3: 197.
20. Takahashi H, Saitoh K, Kishi H, Parsons PG. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumors. Virchows Arch 1995: 427: 283.
21. Zakut R, Perlis R, Eliyahu S, et al. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 1993: 8: 2221.
22. Reed JA, Bogdany JK, McNutt NS. Expression of the mast cell growth factor interleukin 3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol 1996: 23: 495.
23. Meininger CJ, Zetter BR. Mast cells and angiogenesis. Semin Cancer Biol 1992: 3: 73.
24. Tharp MD. The interaction between mast cells and endothelial cells. J Invest Dermatol 1989: 93: 107s.